AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33781066 — intervention group
Group type: COMPARATOR
Intervention: Positive control group (unfilled retrocavities)
Number of subjects: 70
Study 33781066 — intervention group
Group type: COMPARATOR
Intervention: Negative control group (sealed with flowable composite material)
Number of subjects: 70
Study 36099688 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance-enhanced behavior therapy for TTM (AEBT‐TTM)
Number of subjects: 85
Study 36099688 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation and supportive therapy (PST)
Number of subjects: 85
Study 34050429 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA) with continuous epidural bupivacaine and sufentanil infusion
Number of subjects: 50
Study 34050429 — intervention group
Group type: COMPARATOR
Intervention: Paravertebral analgesia (PVA) with continuous paravertebral bupivacaine infusion and intravenous morphine
Number of subjects: 50
Study 32846929 — intervention group
Group type: EXPERIMENTAL
Intervention: K-diet
Number of subjects: 10
Study 32846929 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 10
Study 35590794 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% sodium chloride
Number of subjects: 18
Study 35590794 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% glucose
Number of subjects: 18
Study 35590794 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer’s solution
Number of subjects: 18
Study 35590794 — intervention group
Group type: COMPARATOR
Intervention: Control (no liquid administered)
Number of subjects: 18
Study 34656955 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg MOFs daily for 3 months
Number of subjects: 97
Study 34656955 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily for 3 months
Number of subjects: 97
Study 34656955 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg MOFs
Number of subjects: 97
Study 34332956 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg bolus then 0.12 mg/kg/h infusion for the first 24 hours postoperative
Number of subjects: 90
Study 34332956 — intervention group
Group type: COMPARATOR
Intervention: Ketamine 0.5 mg/kg and Mg sulfate 50 mg/kg, then ketamine 0.12 mg/kg/h and Mg sulfate 8 mg/kg/h infusions for the first 24 hours postoperative
Number of subjects: 90
Study 34428440 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message-based support (4 texts per week for 6 months) covering diet, physical activity, smoking, general cardiovascular health, and medication adherence.
Number of subjects: 246
Study 34428440 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message-based support (4 texts per week for 6 months).
Number of subjects: 246
Study 34428440 — intervention group
Group type: COMPARATOR
Intervention: Standard care only (control group).
Number of subjects: 246
Study 33721365 — intervention group
Group type: EXPERIMENTAL
Intervention: Letibotulinum toxin A (LeBA)
Number of subjects: 240
Study 33721365 — intervention group
Group type: COMPARATOR
Intervention: Onabotulinum toxin A (OnBA)
Number of subjects: 240
Study 32609422 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFRCys
Number of subjects: 7217
Study 32609422 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR Cr-Cys
Number of subjects: 7217
Study 32609422 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFRCr-Cys-B2M
Number of subjects: 7217
Study 32609422 — intervention group
Group type: EXPERIMENTAL
Intervention: All filtration markers combined
Number of subjects: 7217
Study 32609422 — intervention group
Group type: EXPERIMENTAL
Intervention: Major macrovascular events
Number of subjects: 7217
Study 32609422 — intervention group
Group type: EXPERIMENTAL
Intervention: Microvascular events
Number of subjects: 7217
Study 32609422 — intervention group
Group type: EXPERIMENTAL
Intervention: All-cause mortality
Number of subjects: 7217
Study 35637272 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg oral methylphenidate
Number of subjects: 36
Study 35637272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 33534742 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-dug well (HDW)
Number of subjects: 14
Study 33534742 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 14
Study 33825964 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 5
Study 32039864 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (four face-to-face training sessions and two virtual training sessions using educational videos)
Number of subjects: 67
Study 32039864 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 67
Study 34636314 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (Botox)
Number of subjects: 11
Study 33690132 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual compression
Number of subjects: 80
Study 33690132 — intervention group
Group type: COMPARATOR
Intervention: Mechanical compression (using radial TR band)
Number of subjects: 80
Study 33690132 — intervention group
Group type: COMPARATOR
Intervention: Mechanical compression
Number of subjects: 80
Study 34653245 — intervention group
Group type: EXPERIMENTAL
Intervention: OVX836 (30 µg, 90 µg, or 180 µg)
Number of subjects: 36
Study 34653245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 33341367 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-domain cognitive training (MDCT) for 12 weeks (24 sessions)
Number of subjects: 32
Study 33341367 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 33341367 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-domain cognitive training (MDCT)
Number of subjects: 32
Study 34843383 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise program
Number of subjects: 415
Study 34843383 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 415
Study 34843383 — intervention group
Group type: COMPARATOR
Intervention: Control group (electronic osteoarthritis information)
Number of subjects: 415
Study 32331244 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced energy diet (1200 kcal/day)
Number of subjects: 500
Study 32331244 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (2000 kcal/day)
Number of subjects: 500
Study 32331244 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal GDM management (insulin/metformin)
Number of subjects: 500
Study 36074245 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation during pregnancy
Number of subjects: 300
Study 36074245 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 300
Study 34403046 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% fly ash + 40% vermicompost
Number of subjects: 21
Study 34403046 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% fly ash + 40% vermicompost
Number of subjects: 21
Study 34403046 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate concentrations of fly ash and vermicompost
Number of subjects: 21
Study 34403046 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% soil + 20% fly ash + 40% vermicompost
Number of subjects: 21
Study 34403046 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of vermicompost
Number of subjects: 21
Study 34403046 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of fly ash
Number of subjects: 21
Study 34403046 — intervention group
Group type: EXPERIMENTAL
Intervention: Marginal addition of fly ash to vermicompost
Number of subjects: 21
Study 34403046 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment effects on pH
Number of subjects: 21
Study 33270066 — intervention group
Group type: EXPERIMENTAL
Intervention: Straumann SLActive
Number of subjects: 30
Study 33270066 — intervention group
Group type: EXPERIMENTAL
Intervention: Astra OsseoSpeed
Number of subjects: 30
Study 33270066 — intervention group
Group type: EXPERIMENTAL
Intervention: Thommen Implant System
Number of subjects: 30
Study 36171046 — intervention group
Group type: EXPERIMENTAL
Intervention: OnTrack system for arm and hand rehabilitation (12 weeks duration)
Number of subjects: 12
Study 36171046 — intervention group
Group type: EXPERIMENTAL
Intervention: OnTrack system for arm and hand rehabilitation
Number of subjects: 12
Study 32853672 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (AZM) in addition to hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r)
Number of subjects: 111
Study 32853672 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r)
Number of subjects: 111
Study 36257846 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic acupuncture (MA) with adhesive acupuncture magnets placed on 5 predetermined meridian points for 48 hours
Number of subjects: 126
Study 36257846 — intervention group
Group type: COMPARATOR
Intervention: Placebo (non-magnetic adhesive metal disks placed in the same locations)
Number of subjects: 126
Study 36257846 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplemental treatment)
Number of subjects: 126
Study 33660540 — intervention group
Group type: EXPERIMENTAL
Intervention: Active decision making
Number of subjects: 306
Study 33660540 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognosis
Number of subjects: 306
Study 33660540 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and caregiving responsibilities
Number of subjects: 306
Study 33660540 — intervention group
Group type: EXPERIMENTAL
Intervention: Random decision-making strategies
Number of subjects: 306
Study 32039724 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1700 and 2000 mg/d)
Number of subjects: 93
Study 32039724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 32039724 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin exposure
Number of subjects: 93
Study 32039724 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal testosterone and androstenedione levels
Number of subjects: 93
Study 35470030 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0
Study 35470030 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0
Study 35470030 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33388335 — intervention group
Group type: EXPERIMENTAL
Intervention: Fact-checking labels attributed to algorithms, news media, health institutions, research universities, or fact-checking organizations
Number of subjects: 1198
Study 33388335 — intervention group
Group type: COMPARATOR
Intervention: Misinformation control
Number of subjects: 1198
Study 33388335 — intervention group
Group type: EXPERIMENTAL
Intervention: Fact-checking labels from universities and health institutions
Number of subjects: 1198
Study 32446470 — intervention group
Group type: EXPERIMENTAL
Intervention: Autodialer
Number of subjects: 84976
Study 32446470 — intervention group
Group type: EXPERIMENTAL
Intervention: Text
Number of subjects: 84976
Study 32446470 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed
Number of subjects: 84976
Study 32446470 — intervention group
Group type: COMPARATOR
Intervention: No reminder
Number of subjects: 84976
Study 36154809 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-pelvis radiotherapy (WPRT)
Number of subjects: 69
Study 36154809 — intervention group
Group type: COMPARATOR
Intervention: Prostate-only radiotherapy (PORT)
Number of subjects: 69
Study 36351721 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal administration of human-derived neural stem cells (hNSCs) for 4 consecutive weeks
Number of subjects: 60
Study 36351721 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group) for 4 consecutive weeks
Number of subjects: 60
Study 32228531 — intervention group
Group type: EXPERIMENTAL
Intervention: PEBRA model (peer-educator coordinated ART services)
Number of subjects: 300
Study 32228531 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (ART services coordinated by the nurse)
Number of subjects: 300
Study 35737872 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride (NaF) varnish with standard oral hygiene instructions (OHI)
Number of subjects: 99
Study 35737872 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF plus tricalcium phosphate varnish with standard OHI
Number of subjects: 99
Study 35737872 — intervention group
Group type: COMPARATOR
Intervention: Standard oral hygiene instructions (OHI)
Number of subjects: 99
Study 34797188 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Training (MT)
Number of subjects: 36
Study 34797188 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness Training (MT) + Aerobic Training (AT)
Number of subjects: 36
Study 34797188 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 36
Study 32916126 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (anti-PD-1) alone or combined with ipilimumab (anti-CTLA-4)
Number of subjects: 101
Study 32916126 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-γ in vitro exposure
Number of subjects: 101
Study 32916126 — intervention group
Group type: EXPERIMENTAL
Intervention: Conserved IFN-γ transcriptome response in melanoma cells
Number of subjects: 101
Study 32916126 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnitude of the antitumor T cell response and corresponding downstream IFN-γ signaling
Number of subjects: 101
Study 34261354 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with 20 μl of 10^6 conidia/ml suspensions of C. fioriniae and C. nymphaeae isolates
Number of subjects: 3
Study 34261354 — intervention group
Group type: COMPARATOR
Intervention: Sterile distilled water (control)
Number of subjects: 3
Study 33444189 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD) including at least 6 gluten-free breads per day + 200g of gluten-free penne pasta per week + 6 rice flavour capsules per day
Number of subjects: 200
Study 33444189 — intervention group
Group type: COMPARATOR
Intervention: Gluten-containing diet including at least 6 gluten-containing breads per day + 200g of gluten-containing penne pasta per week + 6 vital gluten-containing capsules per day
Number of subjects: 200
Study 33444189 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 200
Study 34406407 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss and exercise (WLEX)
Number of subjects: 84
Study 34406407 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (WL)
Number of subjects: 84
Study 33784706 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen supplementation during exercise
Number of subjects: 13
Study 33784706 — intervention group
Group type: COMPARATOR
Intervention: Medical air during exercise
Number of subjects: 13
Study 32857254 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed cessation messages
Number of subjects: 135
Study 32857254 — intervention group
Group type: COMPARATOR
Intervention: Loss-framed cessation messages
Number of subjects: 135
Study 32857254 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed messages
Number of subjects: 135
Study 32857254 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed messages
Number of subjects: 135
Study 32798327 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis via acute services
Number of subjects: 915
Study 32798327 — intervention group
Group type: COMPARATOR
Intervention: Diagnosis via other secondary care specialties
Number of subjects: 915
Study 32798327 — intervention group
Group type: COMPARATOR
Intervention: Direct referral from primary care to haematology
Number of subjects: 915
Study 36170749 — intervention group
Group type: EXPERIMENTAL
Intervention: mART (maternal antiretroviral therapy)
Number of subjects: 2431
Study 36170749 — intervention group
Group type: COMPARATOR
Intervention: iNVP (infant nevirapine prophylaxis)
Number of subjects: 2431
Study 36170749 — intervention group
Group type: EXPERIMENTAL
Intervention: mART
Number of subjects: 2431
Study 36170749 — intervention group
Group type: COMPARATOR
Intervention: iNVP
Number of subjects: 2431
Study 32956888 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine via smart glasses during virtual ward rounds
Number of subjects: 103
Study 32956888 — intervention group
Group type: COMPARATOR
Intervention: Physical ward rounds conducted by resident and specialist
Number of subjects: 103
Study 32956888 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative survey post-study
Number of subjects: 103
Study 36408821 — intervention group
Group type: EXPERIMENTAL
Intervention: HR20033 in fasted condition
Number of subjects: 28
Study 36408821 — intervention group
Group type: COMPARATOR
Intervention: HR20033 in fed condition
Number of subjects: 28
Study 36408821 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple oral doses of HR20033
Number of subjects: 28
Study 36408821 — intervention group
Group type: EXPERIMENTAL
Intervention: Both studies
Number of subjects: 28
Study 34147377 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented soybean meal
Number of subjects: 13
Study 34147377 — intervention group
Group type: COMPARATOR
Intervention: Non-fermented soybean meal
Number of subjects: 13
Study 35908731 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytisine plus counselling
Number of subjects: 869
Study 35908731 — intervention group
Group type: COMPARATOR
Intervention: Counselling alone
Number of subjects: 869
Study 33711681 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 42
Study 33711681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 616084002 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser Peripheral Iridotomy (LPI)
Number of subjects: 39
Study 35681162 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified exercise therapy (including dietary intervention for the 'obesity subgroup')
Number of subjects: 15
Study 35681162 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified exercise therapy (for the 'obesity subgroup')
Number of subjects: 15
Study 35681162 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified exercise therapy (for the 'high muscle strength subgroup')
Number of subjects: 15
Study 35681162 — intervention group
Group type: EXPERIMENTAL
Intervention: General knee OA treatment
Number of subjects: 15
Study 33098189 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care (including use of the DecisionKEYS decision aid)
Number of subjects: 164
Study 33098189 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 164
Study 33098189 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with less than 20% decline in 3-IGI PRO score after two treatment cycles
Number of subjects: 164
Study 33098189 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with a 3-IGI decline of 20% or more
Number of subjects: 164
Study 616083343 — intervention group
Group type: COMPARATOR
Intervention: Tropicamide 0.5%
Number of subjects: 60
Study 616083343 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine 1%
Number of subjects: 60
Study 33277990 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 85
Study 33277990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 32513226 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive face-to-face sessions (mean dose delivered 10.9 of 12 sessions)
Number of subjects: 610
Study 32513226 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance phone calls (mean dose delivered 7.7 of 9 calls)
Number of subjects: 610
Study 32513226 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of intensive sessions (>6) and maintenance calls (>8)
Number of subjects: 610
Study 32513226 — intervention group
Group type: COMPARATOR
Intervention: Control group (zero dose)
Number of subjects: 610
Study 36478339 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning Through Play plus Culturally adapted Cognitive Behaviour Therapy (LTP+CaCBT)
Number of subjects: 26
Study 36478339 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 26
Study 33880135 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal EphB2-Fc
Number of subjects: 48
Study 33880135 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracolonic TNBS
Number of subjects: 48
Study 33880135 — intervention group
Group type: COMPARATOR
Intervention: Intracolonic vehicle (control group)
Number of subjects: 48
Study 32148330 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar spinal manipulation (SMT)
Number of subjects: 80
Study 32148330 — intervention group
Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 80
Study 35218193 — intervention group
Group type: COMPARATOR
Intervention: 2 eggs/week (control)
Number of subjects: 51
Study 35218193 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 eggs/week
Number of subjects: 51
Study 35218193 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 eggs/week
Number of subjects: 51
Study 33358255 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term cilostazol treatment
Number of subjects: 249
Study 33358255 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 249
Study 33358255 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) in the first postoperative year
Number of subjects: 249
Study 33358255 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 249
Study 33358255 — intervention group
Group type: EXPERIMENTAL
Intervention: High high-sensitivity chronic reactive protein level, diabetic neuropathy, sole use of an oral hypoglycemic agent, and lack of supervised exercise
Number of subjects: 249
Study 33358255 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without DM
Number of subjects: 249
Study 33358255 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with DM
Number of subjects: 249
Study 34427052 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg/day)
Number of subjects: 18
Study 34427052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 33721199 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 IU intranasal insulin
Number of subjects: 115
Study 33721199 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 IU intranasal insulin
Number of subjects: 115
Study 33721199 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 115
Study 32003141 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 4153